Use of Ctdna in Patients With Gastrointestinal Tract Tumors

Recruiting now

Conditions studied: Pancreas Cancer, Colon Cancer, Biliary Tract Cancer

In brief

This study will evaluate the use of ctDNA in the clinical management of patients with tumors of the gastrointestinal tract.

Key facts

Study ID

NCT06202131

Run by

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

People needed

100

Starts

2023-11-01

Expected to finish

2028-11-01

Last updated by the study team

2025-09-02

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >18 years
• PS ECOG <2;
• Histological diagnosis of gastrointestinal cancer: esophageal, gastric, intestinal, pancreatic, biliary tract neoplasms;
• Radiological evidence of resectable/locally advanced/metastatic disease on the date of signing the written informed consent;
• Adequate organ and function;
• Availability of tumor histological material.

You may not qualify if…

• No histological diagnosis of neoplasia of the gastrointestinal tract.
• No written informed consent.

Where it is running

• Policlinico Agostino Gemelli — Rome, Lazio, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.